This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/uk/523172-uk-under-40s-astrazeneca/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| UK vaccination committee says under-40s should opt for alternative to blood clot-linked AstraZeneca… unless it causes ‘delays’ | UK vaccination committee says under-40s should opt for alternative to blood clot-linked AstraZeneca… unless it causes ‘delays’ |
| (4 months later) | |
| The UK’s Joint Committee on Vaccination and Immunisation (JCVI) has advised that under-40s be vaccinated with an alternative to the AstraZeneca Covid-19 jab due to cases of blood clotting – but only if doing so causes no “delays". | The UK’s Joint Committee on Vaccination and Immunisation (JCVI) has advised that under-40s be vaccinated with an alternative to the AstraZeneca Covid-19 jab due to cases of blood clotting – but only if doing so causes no “delays". |
| JCVI Chairman Professor Wei Shen Lim said on Friday that “as Covid-19 rates continue to come under control”, the committee is “advising that adults aged 18 - 39 years with no underlying health conditions are offered an alternative to the Oxford/AstraZeneca vaccine, if available, and if it does not cause delays in having the vaccine”. | JCVI Chairman Professor Wei Shen Lim said on Friday that “as Covid-19 rates continue to come under control”, the committee is “advising that adults aged 18 - 39 years with no underlying health conditions are offered an alternative to the Oxford/AstraZeneca vaccine, if available, and if it does not cause delays in having the vaccine”. |
| It is unclear whether this means some young people will only be offered the AstraZeneca vaccine, whose risks are judged by many to outweigh the benefits in the younger population. | It is unclear whether this means some young people will only be offered the AstraZeneca vaccine, whose risks are judged by many to outweigh the benefits in the younger population. |
| Earlier last month, the JCVI revealed that an alternative would be offered to those under the age of 30. However, this has since been raised to those under the age of 40. | Earlier last month, the JCVI revealed that an alternative would be offered to those under the age of 30. However, this has since been raised to those under the age of 40. |
| As of two weeks ago, at least 168 recipients of AstraZeneca’s Covid-19 vaccine in the UK had suffered serious blood clots, with at least 32 deaths. Risk of blood clotting is considered to be slightly higher for those who are of a younger age. | As of two weeks ago, at least 168 recipients of AstraZeneca’s Covid-19 vaccine in the UK had suffered serious blood clots, with at least 32 deaths. Risk of blood clotting is considered to be slightly higher for those who are of a younger age. |
| After numerous blood clot cases following AstraZeneca shots were detected around the world, several countries temporarily halted its use for certain age groups. Still, the European Medicines Agency insists the vaccine’s benefits outweigh the risks. | After numerous blood clot cases following AstraZeneca shots were detected around the world, several countries temporarily halted its use for certain age groups. Still, the European Medicines Agency insists the vaccine’s benefits outweigh the risks. |
| Think your friends would be interested? Share this story! | Think your friends would be interested? Share this story! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |